What is Rijuven?
Rijuven operates at the intersection of healthcare and technology, focusing on making medical services universally accessible. The company's innovative product suite, including CardioSleeve, Rejiva EKG, and Clinic in a Bag, is designed to facilitate remote patient examinations and streamline chronic care management. By integrating connected devices with advanced cloud-based analysis, Rijuven enhances patient monitoring and engagement across diverse settings, from urban medical centers to remote refugee camps. This strategic approach aims to bridge critical gaps in healthcare access, empowering providers to serve underserved populations worldwide.
How much funding has Rijuven raised?
Rijuven has raised a total of $4.2M across 4 funding rounds:
Private Equity
$875K
Private Equity
$543K
Private Equity
$500K
Private Equity
$2.3M
Private Equity (2012): $875K, investors not publicly disclosed
Private Equity (2012): $543K, investors not publicly disclosed
Private Equity (2014): $500K, investors not publicly disclosed
Private Equity (2017): $2.3M, investors not publicly disclosed
What's next for Rijuven?
With its recent major strategic investment, Rijuven is poised for significant expansion and further development of its connected healthcare platform. The substantial capital infusion, reflected in the total funding of $4.2M, will likely be directed towards scaling operations, enhancing technological capabilities, and broadening its global reach. This strategic backing signals strong investor confidence in Rijuven's model for democratizing healthcare access and its potential to disrupt traditional care delivery paradigms. The company's focus on remote monitoring and chronic care management aligns with the growing demand for telehealth solutions, positioning Rijuven for sustained growth and impact in the evolving healthcare landscape.
See full Rijuven company page
